Manchester Capital Management LLC Eli Lilly & CO Transaction History

Manchester Capital Management LLC

$829 Million
Q3 2024

A detailed history of Manchester Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Manchester Capital Management LLC holds 4,704 shares of LLY stock, worth $3.75 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

4,704

Previous 4,166 12.91%

Holding current value

$3.75 Million

Previous $3.77 Million 10.5%

% of portfolio

0.5%

Previous 0.46%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $415,411 - $516,490	538 Added 12.91%	4,704 $4.17 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $84,809 - $106,357	117 Added 2.89%	4,166 $3.77 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $607,005 - $812,087	1,025 Added 33.9%	4,049 $3.15 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $77,202 - $91,012	147 Added 5.11%	3,024 $1.76 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $86,505 - $119,260	199 Added 7.43%	2,877 $1.55 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $286,554 - $383,156	817 Added 43.9%	2,678 $1.26 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $931 - $1,094	-3 Reduced 0.16%	1,861 $639,000
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $296 - $337	-1 Reduced 0.05%	1,864 $603,000
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $253,923 - $298,142	911 Added 95.49%	1,865 $605,000
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $11,734 - $14,583	-50 Reduced 4.98%	954 $273,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $5,171 - $6,417	23 Added 2.34%	1,004 $277,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $4,875 - $5,999	22 Added 2.29%	981 $227,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $1,624 - $2,101	9 Added 0.95%	959 $220,000
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $1,478 - $1,914	-9 Reduced 0.94%	950 $177,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $913 - $1,208	7 Added 0.74%	959 $162,000
Q3 2020 Oct 27, 2020	SELL	$146.22 - $169.13 $183,944 - $212,765	-1,258 Reduced 56.92%	952 $141,000
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $27,765 - $30,201	-260 Reduced 10.53%	2,210 $247,000
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $19,294 - $22,776	260 Added 11.76%	2,470 $191,000
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $4,097 - $4,394	50 Added 2.31%	2,210 $187,000
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $166,471 - $184,766	2,160	2,160 $185,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Account

Manchester Capital Management LLC Eli Lilly & CO Transaction History